PELI1 and prostate carcinoma: Considering our previous findings that PELI1 showed higher expression in breast cancer than adjacent tissues, we examined whether PELI1 is commonly abundant in other cancers by a multiple tumor tissue microarray assay, including colon cancer, lung cancer, rectum cancer, breast cancer and prostate cancer.